Shakira W Burton1, Christina Riojas, Gail Gesin, Charlotte B Smith, Vashti Bandy, Ronald Sing, Tamar Roomian, Meghan K Wally, Cynthia W Lauer. 1. From the Acute Care Surgery Division (S.W.B., C.R., C.B.S., V.B., C.W.L.), Atrium Health-Carolinas Medical Center; Division of Pharmacy (G.G.), FH Sammy Ross Trauma Center (R.S.), Atrium Health; Department of Orthopaedic Surgery (T.R., M.K.W., M.J.B., J.R.H., D.L., S.O., R.B.S., Z.Y.), Atrium Health Musculoskeletal Institute; NC Poison Control (M.B.), Department of Emergency Medicine (M.G., C.G., M.R.), Patient Safety (S.J.), Atrium Health; OrthoCarolina Research Institute (S.O.); Department of Internal Medicine (A.S.), Atrium Health Information and Analytic Services (D.M.S.), Atrium Health, Charlotte; GIV Hydration (B.W.), Huntersville; and Adult Psychiatry, Atrium Health (S.W.), Charlotte, NC.
Abstract
BACKGROUND: Rib fractures are common in trauma patients and are associated with significant morbidity and mortality. Adequate analgesia is essential to avoid the complications associated with rib fractures. Opioids are frequently used for analgesia in these patients. This study compared the effect of a multimodal pain regimen (MMPR) on inpatient opioid use and outpatient opioid prescribing practices in adult trauma patients with rib fractures. STUDY DESIGN: A pre-post cohort study of adult trauma patients with rib fractures was conducted at a Level I trauma center before (PRE) and after (POST) implementation of an MMPR. Patients on long-acting opioids before admission and those on continuous opioid infusions were excluded. Primary outcomes were oral opioid administration during the first 5 days of hospitalization and opioids prescribed at discharge. Opioid data were converted to morphine milligram equivalents (MMEs). RESULTS: Six hundred fifty-three patients met inclusion criteria (323 PRE, 330 POST). There was a significant reduction in the daily MME during the second through fifth days of hospitalization; and the average inpatient MME over the first five inpatient days (23 MME PRE vs. 17 MME POST, p = 0.0087). There was a significant reduction in the total outpatient MME prescribed upon discharge (322 MME PRE vs. 225 MME POST, p = 0.006). CONCLUSION: The implementation of an MMPR in patients with rib fractures resulted in significant reduction in inpatient opioid consumption and was associated with a reduction in the quantity of opiates prescribed at discharge. LEVEL OF EVIDENCE: Therapeutic/Care Management; level IV.
BACKGROUND: Rib fractures are common in trauma patients and are associated with significant morbidity and mortality. Adequate analgesia is essential to avoid the complications associated with rib fractures. Opioids are frequently used for analgesia in these patients. This study compared the effect of a multimodal pain regimen (MMPR) on inpatient opioid use and outpatient opioid prescribing practices in adult trauma patients with rib fractures. STUDY DESIGN: A pre-post cohort study of adult trauma patients with rib fractures was conducted at a Level I trauma center before (PRE) and after (POST) implementation of an MMPR. Patients on long-acting opioids before admission and those on continuous opioid infusions were excluded. Primary outcomes were oral opioid administration during the first 5 days of hospitalization and opioids prescribed at discharge. Opioid data were converted to morphine milligram equivalents (MMEs). RESULTS: Six hundred fifty-three patients met inclusion criteria (323 PRE, 330 POST). There was a significant reduction in the daily MME during the second through fifth days of hospitalization; and the average inpatient MME over the first five inpatient days (23 MME PRE vs. 17 MME POST, p = 0.0087). There was a significant reduction in the total outpatient MME prescribed upon discharge (322 MME PRE vs. 225 MME POST, p = 0.006). CONCLUSION: The implementation of an MMPR in patients with rib fractures resulted in significant reduction in inpatient opioid consumption and was associated with a reduction in the quantity of opiates prescribed at discharge. LEVEL OF EVIDENCE: Therapeutic/Care Management; level IV.
Authors: Nichole K Ingalls; Zachary A Horton; Matthew Bettendorf; Ira Frye; Carlos Rodriguez Journal: J Am Coll Surg Date: 2009-12-24 Impact factor: 6.113
Authors: Joshua J Ofman; Catherine H MacLean; Walter L Straus; Sally C Morton; Marc L Berger; Elizabeth A Roth; Paul Shekelle Journal: J Rheumatol Date: 2002-04 Impact factor: 4.666
Authors: Benjamin T Flagel; Fred A Luchette; R Lawrence Reed; Thomas J Esposito; Kimberly A Davis; John M Santaniello; Richard L Gamelli Journal: Surgery Date: 2005-10 Impact factor: 3.982
Authors: Susan L Calcaterra; Traci E Yamashita; Sung-Joon Min; Angela Keniston; Joseph W Frank; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2016-05 Impact factor: 5.128